We have recently demonstrated a direct physical interaction between αvβ6 and a member of the MAP kinase family, extracellular signal-regulated kinase 2 (ERK2) which defines a novel paradigm of integrin-mediated signalling in cancer (Ahmed et al, 2002). The gene discussed is MAPK1; the disease is cancer.